Scientific Zambon Pharma 1 Settembre 2016 Zambon launches Xadago® (safinamide) in Norway for patients with mid- to late-stage Parkinson's disease
Scientific Zambon Pharma 6 Luglio 2016 Zambon lauches Xadago® (safinamide) in the Netherlands for patients with mid-to-late-stage Parkinson’s Disease